Seattle Genetics and the University of Washington are pleased to offer one, 2-year Health Economics and Outcomes Research (HEOR) Fellowship position for 2020-2022. This local partnership enables fellows to spend their first year at the University of Washington (Seattle, WA) School of Pharmacy, The CHOICE Institute, and the second year at Seattle Genetics (Seattle, WA). This fellowship program is designed to help meet the growing need for expertise in HEOR and evaluation of pharmaceuticals and other health care technologies, the fellowship combines 1 year of academic study with 1 year of industry experience to provide both the theoretical tools and the practical experience to become a skilled researcher in this increasingly important field.
The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute is housed within the University of Washington School of Pharmacy. Faculty in our program (1) provide advanced research training for graduate students, post-doctoral fellows and clinicians (PharmDs, MDs); (2) conduct rigorous scientific research in economic evaluations and outcomes of pharmaceuticals and other health technologies, and (3) translate and disseminate the results of research into clinical practice and healthcare policy, with the goal of improving patient care. CHOICE faculty participating in the fellowship are dedicated to excellence in their teaching and research. Each is trained either as a health economist or health services researcher and all have an extensive history of effective economic evaluations and pharmacoepidemiologic research.
Seattle Genetics is an emerging multi-product, global biotechnology company that develops and commercializes transformative therapies targeting cancer to make a meaningful difference in people’s lives. ADCETRIS® (brentuximab vedotin) utilizes the company’s industry-leading antibody-drug conjugate (ADC) technology and is currently approved for the treatment of multiple CD30-expressing lymphomas. Beyond ADCETRIS, the company has established a pipeline of novel targeted therapies at various stages of clinical testing, including three in ongoing pivotal trials for solid tumors. In addition, we are leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents in clinical trials targeting hematologic malignancies and solid tumors.
The objective of the first year of this fellowship is to educate fellows on the principles and methods used in health economics and outcomes research, including an overview of pharmaceutical economics, general health policy, economic assessment methodologies, health services research design, and statistical analysis through an individualized program of coursework provided through the University of Washington in consultation with the program director. Fellows will be required to develop, under the guidance of their advisors at the University of Washington and Seattle Genetics, a research project leading to a thesis.
The second year provides fellows experience in applying the HEOR skills gained during their first year of the program to real-world development and commercialization of a product within the industry setting. After completion of the program, fellows will have a solid understanding of HEOR methodologies as well as firsthand experience in applying their learnings in an industry setting, laying the foundation for a successful career in HEOR.
Compensation includes a competitive stipend, basic medical insurance, conference attendance, full tuition coverage for the MS program, relocation to Seattle (if applicable), and holiday/vacation time. A Master’s (MS) Degree is awarded upon completion of all course requirements and thesis project.
Application Instructions: Our PPS Application priority deadline is November 29, 2019. Please submit the following via PPS to request an interview with us at PPS:
Three formal letters of recommendation should be either submitted via PPS or sent directly to email@example.com (by the applicant or the letter writer) no later than December 13, 2019. NOTE: We welcome letters to be submitted earlier than this to be taken into consideration for your interview request. You may combine any materials as a single PDF file to circumvent the file upload limit in PPS.
Contact Marina Gano, firstname.lastname@example.org, the Graduate Program and Operations Manager for the CHOICE Institute with questions about applying.
Applicants for this fellowship must have a degree in pharmacy and have some research experience (preference will be given to those with a high academic standing). Excellent written and verbal communication skills are also essential.
Selection of fellows will be made by a steering committee composed of the University of Washington faculty members and representatives from Seattle Genetics.
Due to visa restrictions, we can only consider applicants who are U.S. citizens or Permanent Residents (green card holders).